Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
This report contains market size and forecasts of Mildronate Dihydrate in global, including the following market information:
Global Mildronate Dihydrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mildronate Dihydrate Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Mildronate Dihydrate companies in 2021 (%)
The global Mildronate Dihydrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mildronate Dihydrate include Grindeks. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mildronate Dihydrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mildronate Dihydrate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Mildronate Dihydrate Market Segment Percentages, by Type, 2021 (%)
Capsule
Injection
Tablet
Global Mildronate Dihydrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Mildronate Dihydrate Market Segment Percentages, by Application, 2021 (%)
Cardiovascular Disease
Others
Global Mildronate Dihydrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Mildronate Dihydrate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mildronate Dihydrate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mildronate Dihydrate revenues share in global market, 2021 (%)
Key companies Mildronate Dihydrate sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Mildronate Dihydrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grindeks